Swiss pharmaceutical giant Roche announced a $50 billion investment in the U.S. over the next five years, creating 12,000 jobs. The investment will focus on high-tech research and development sites and new manufacturing facilities in states like California, Indiana, Massachusetts, and Pennsylvania. This move aligns with U.S. President Donald Trump’s push for foreign businesses to invest more in the U.S., although the announcement does not mention tariffs. Roche’s CEO emphasized the company’s commitment to the U.S. market, where it already operates 15 R&D centers and 13 manufacturing sites. The planned expansion will increase Roche’s U.S. footprint to 24 sites across eight states.
— new from AP News
